A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Conclusions: The miRNA array identified nine dysregulated miRNAs from clinical samples. This panel of nine-miRNA signature provides predictive and prognostic value of patients with UCB.
PMID: 30026881 [PubMed - in process]
Source: Disease Markers - Category: Laboratory Medicine Tags: Dis Markers Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Genetics | Japan Health | Laboratory Medicine | Urology & Nephrology